Stoneridge (SRI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
9 Apr, 2026Executive summary
The annual meeting is scheduled for May 19, 2026, and will be held virtually, with shareholders voting on key proposals including director elections, auditor ratification, executive compensation, and an amendment to the long-term incentive plan.
In 2025, net sales decreased by 5.2% due to lower customer production volumes, with a net loss increase of $86.3 million, primarily from lower operating income and a valuation allowance for deferred tax assets.
A CEO transition occurred in April 2026, with Natalia Noblet succeeding James Zizelman, who remains as a strategic advisor and board member.
Voting matters and shareholder proposals
Shareholders will vote to elect nine directors for one-year terms, ratify Ernst & Young LLP as the independent auditor, approve executive compensation on an advisory basis, and approve an amendment to increase shares available under the 2025 Long-Term Incentive Plan.
The board recommends voting FOR all proposals.
Shareholder proposals for the 2027 meeting must be submitted by December 10, 2026, for inclusion in proxy materials.
Board of directors and corporate governance
Seven of nine director nominees are independent; three are female, and the board has diverse backgrounds and skills.
The board has four standing committees: Audit, Compensation, Nominating and Corporate Governance, and Compliance and Ethics, all composed of independent directors.
Annual board and committee self-assessments are conducted, and the board separates the roles of CEO and Chairman.
Shareholders have the right to communicate with the board and nominate directors.
Latest events from Stoneridge
- Annual meeting covers director elections, auditor ratification, and incentive plan amendment.SRI
Proxy filing9 Apr 2026 - 2025 outperformed end markets with 69%–70% MirrorEye growth and strong 2026 targets.SRI
Q4 202512 Mar 2026 - Q2 2024 saw margin gains, EPS growth, and updated guidance as key tech launches accelerated.SRI
Q2 20242 Feb 2026 - Control Devices sold for $59M to focus on advanced electronics and reduce debt.SRI
Status update2 Feb 2026 - MirrorEye and Smart 2 drive growth through innovation, safety, and regulatory compliance.SRI
CL King’s 22nd Annual Best Ideas Conference 202420 Jan 2026 - Q3 sales and earnings declined, but cash flow and MirrorEye adoption showed improvement.SRI
Q3 202417 Jan 2026 - Growth driven by MirrorEye, Smart 2, and operational improvements despite market softness.SRI
Stephens 26th Annual Investment Conference | NASH202413 Jan 2026 - MirrorEye/Mirai and Smart 2 growth offset market declines, driving margin and cash flow gains.SRI
Q4 202426 Dec 2025 - Margin gains and record product sales drive Q1, with guidance reaffirmed despite net loss.SRI
Q1 202524 Dec 2025